Franklin Street Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $538K | Hold |
|
|||||
|
2025
Q1 | $450K | Hold |
|
|||||
|
2024
Q4 | $451K | Hold |
|
|||||
|
2024
Q3 | $456K | Hold |
|
|||||
|
2024
Q2 | $371K | Hold |
|
|||||
|
2024
Q1 | $305K | Hold |
|
|||||
|
2023
Q4 | $359K | Hold |
|
|||||
|
2023
Q3 | $425K | Buy |
|
|||||
|
2023
Q2 | $352K | Hold |
|
|||||
|
2023
Q1 | $417K | Hold |
|
|||||
|
2022
Q4 | $574K | Hold |
|
|||||
|
2022
Q3 | $630K | Hold |
|
|||||
|
2022
Q2 | $529K | Hold |
|
|||||
|
2022
Q1 | $813K | Hold |
|
|||||
|
2021
Q4 | $693K | Hold |
|
|||||
|
2021
Q3 | $719K | Hold |
|
|||||
|
2021
Q2 | $791K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $596K | Buy |
|
|||||
|
2020
Q3 | $258K | Hold |
|
|||||
|
2020
Q2 | $357K | Hold |
|
|||||
|
2020
Q1 | $150K | Buy |
|
|||||
|
2019
Q4 | $173K | Sell |
|
|||||
|
2019
Q3 | $183K | Buy |
|
|||||
|
2019
Q2 | $53K | Sell |
|
|||||
|
2019
Q1 | $521K | Buy |
|
|||||
|
2018
Q4 | $355K | Buy |
|
|||||
|
2018
Q3 | $328K | Hold |
|
|||||
|
2018
Q2 | $246K | Sell |
|
|||||
|
2018
Q1 | $234K | Hold |
|
|||||
|
2017
Q4 | $241K | Hold |
|
|||||
|
2017
Q3 | $257K | Hold |
|
|||||
|
2017
Q2 | $272K | Hold |
|
|||||
|
2017
Q1 | $412K | Hold |
|
|||||
|
2016
Q4 | $310K | Hold |
|
|||||
|
2016
Q3 | $216K | Sell |
|
|||||
|
2016
Q2 | $196K | Hold |
|
|||||
|
2016
Q1 | $195K | Hold |
|
|||||
|
2015
Q4 | $712K | Hold |
|
|||||
|
2015
Q3 | $787K | Hold |
|
|||||
|
2015
Q2 | $1.03M | Hold |
|
|||||
|
2015
Q1 | $623K | Sell |
|
|||||
|
2014
Q4 | $1.2M | Buy |
|
|||||
|
2014
Q3 | $910K | Hold |
|
|||||
|
2014
Q2 | $1.19M | Hold |
|
|||||
|
2014
Q1 | $984K | Sell |
|
|||||
|
2013
Q4 | $1.06M | Hold |
|
|||||
|
2013
Q3 | $1.01M | Hold |
|
|||||
|
2013
Q2 | $216K | Buy |
|